BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31959493)

  • 1. Primary malignant ovarian carcinoid; management and outcomes.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
    Gynecol Oncol; 2020 Apr; 157(1):101-105. PubMed ID: 31959493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological study of ovarian carcinoid tumours.
    McGrath S; Nicklin J
    Aust N Z J Obstet Gynaecol; 2016 Oct; 56(5):508-513. PubMed ID: 27405920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility-preserving surgery for advanced stage ovarian germ cell tumors.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
    Gynecol Oncol; 2017 Dec; 147(3):493-496. PubMed ID: 29021083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Fertility-Sparing Surgery for Premenopausal Women With Sex Cord-Stromal Tumors Confined to the Ovary.
    Nasioudis D; Frey MK; Chapman-Davis E; Witkin SS; Holcomb K
    Int J Gynecol Cancer; 2017 Nov; 27(9):1826-1832. PubMed ID: 28930803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid: A historical cohort study.
    Kong S; Sun J; Sui X; Zhang S; Qi Y; Ma Y; Li S
    Acta Obstet Gynecol Scand; 2023 Jul; 102(7):935-941. PubMed ID: 37059424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
    Nasioudis D; Chapman-Davis E; Frey MK; Witkin SS; Holcomb K
    J Gynecol Oncol; 2017 Nov; 28(6):e71. PubMed ID: 28758377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base.
    Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Holcomb K
    Gynecol Oncol; 2017 Nov; 147(2):296-301. PubMed ID: 28803748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of 27 ovarian tumors of low malignant potential.
    Demeter A; Csapó Z; Szánthó A; Bálega J; Sipos N; Papp Z
    Eur J Gynaecol Oncol; 2002; 23(5):415-8. PubMed ID: 12440814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
    Yang ZJ; Wei RJ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary.
    Nasioudis D; Mastroyannis SA; Haggerty AF; Giuntoli RL; Morgan MA; Ko EM; Latif NA
    Eur J Obstet Gynecol Reprod Biol; 2020 May; 248():63-70. PubMed ID: 32182501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary ovarian carcinoid tumors.
    Davis KP; Hartmann LK; Keeney GL; Shapiro H
    Gynecol Oncol; 1996 May; 61(2):259-65. PubMed ID: 8626144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic outcomes of uterine preservation for pre-menopausal patients with stage II epithelial ovarian carcinoma.
    Nasioudis D; Mulugeta-Gordon L; McMinn E; Byrne M; Ko EM; Cory L; Haggerty AF; Latif NA
    Int J Gynecol Cancer; 2021 Mar; 31(3):480-483. PubMed ID: 33649017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant germ cell tumors of the ovary: a study of 20 cases.
    Piura B; Dgani R; Zalel Y; Nemet D; Yanai-Inbar I; Cohen Y; Glezerman M
    J Surg Oncol; 1995 Jul; 59(3):155-61. PubMed ID: 7609521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
    Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
    Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population.
    Nasioudis D; Alevizakos M; Holcomb K; Witkin SS
    Maturitas; 2017 Feb; 96():45-50. PubMed ID: 28041594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors.
    Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
    Int J Gynecol Cancer; 2019 Mar; 29(3):554-559. PubMed ID: 30700566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for early stage endometrioid ovarian carcinoma: An analysis of the National Cancer Data Base.
    Nasioudis D; Latif NA; Simpkins F; Cory L; Giuntoli RL; Haggerty AF; Morgan MA; Ko EM
    Gynecol Oncol; 2020 Feb; 156(2):315-319. PubMed ID: 31839340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
    Yang ZJ; Liu ZC; Wei RJ; Li L
    Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary trabecular carcinoid tumor of the ovary.
    Talerman A; Evans MI
    Cancer; 1982 Oct; 50(7):1403-7. PubMed ID: 7104979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.